Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Enterprise Value: 2019-2023

Historic Enterprise Value for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2023 value amounting to $136.5 million.

  • ADC Therapeutics' Enterprise Value rose 471.32% to $136.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $136.5 million, marking a year-over-year increase of 459.70%. This contributed to the annual value of $192.4 million for FY2024, which is 40.91% up from last year.
  • Latest data reveals that ADC Therapeutics reported Enterprise Value of $136.5 million as of Q4 2023, which was up 157.54% from -$237.3 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Enterprise Value ranged from a high of $2.6 billion in Q2 2020 and a low of -$237.3 million during Q3 2023.
  • Over the past 3 years, ADC Therapeutics' median Enterprise Value value was $490.3 million (recorded in 2022), while the average stood at $712.6 million.
  • In the last 5 years, ADC Therapeutics' Enterprise Value surged by 1,610,455.49% in 2020 and then crashed by 164.08% in 2023.
  • ADC Therapeutics' Enterprise Value (Quarterly) stood at -$115.6 million in 2019, then surged by 1,610,455.49% to $2.4 billion in 2020, then fell by 13.47% to $1.1 billion in 2021, then tumbled by 103.39% to -$36.8 million in 2022, then spiked by 471.32% to $136.5 million in 2023.
  • Its last three reported values are $136.5 million in Q4 2023, -$237.3 million for Q3 2023, and -$173.8 million during Q2 2023.